20377 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom; Non condensed pyridines; Hydrogenated derivatives thereof; Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
AGENTS USEFUL FOR TREATING FRIEDREICH'S ATAXIA AND OTHER NEURODEGENERATIVE DISEASES
#302Aryl derivatives and uses thereof
#303Thiol mediated/activated prodrugs of sulfur dioxide (SO) having anti-bacterial activity
#304Method for regulating retinal endothelial cell viability
#305Fluorinated arylalkylaminocarboxamide derivatives
#306Method of inhibiting apolipoprotein-E expression comprising administering a triarylmethyl amine compound
#3072,5-disubstituted arylsulfonamide CCR3 antagonists
#308Method of inhibiting apolipoprotein-E expression comprising administering a triarylmethyl amine compound
#309Patch preparation
#310PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PREVENTING, TREATING, OR REVERSING NEURONAL DYSFUNCTION
#311Composition comprising benproperine derivatives as active ingredients for preventing and treating angiogenesis-related diseases
#312Aryloxyurea compound and pest control agent
#313Prolylcarboxypeptidase inhibitors
#314Composition for maintaining function of platelets
#315Small Molecule Inhibitors of Functions of the HIV-1 Matrix Protein
#316Fe(III) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias
#317Bile Acid Recycling Inhibitors for Treatment of Hypercholemia and Cholestatic Liver Disease
#318Methods and compositions for treating microbial infection using pyrroloquinone
#319Amido compounds as RORγt modulators and uses thereof
#320Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
#3212,5-disubstituted arylsulfonamide CCR3 antagonists
#322Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors
#323Anti-arenaviral compounds
#324Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, Alzheimer'S disease, sleep disorders, Parkinson'S disease, AIDS, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
#325Compositions and methods for the treatment of giardiasis
#326PHARMACEUTICAL COMPOSITION AND METHOD FOR PREVENTING OR TREATING CHRONIC HEART DISEASE
#327RAPIDLY DISPERSING GRANULES, ORALLY DISINTEGRATING TABLETS AND METHODS
#328Inhibitor of protein crosslinking and use of the same
#329Synergistic Combination Therapy
#330Methods for the treatment and prevention of ocular disorders
#331PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PREVENTING, TREATING, OR REVERSING NEURONAL DYSFUNCTION
#332METHODS FOR TREATING NEURAL CELL SWELLING
#333NON-PEPTIDE ANTAGONISTS OF GASTRIN RELEASING PEPTIDE
#334Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
#335Alpha-arylmethoxyacrylate derivative, preparation method thereof, and pharmaceutical composition containing same
#336Dihydropyrimidine compounds and preparation methods, pharmaceutical compositions and uses thereof
#337Combination of dopamine agonists plus first phase secretagogues for the treatment of metabolic disorders
#338Estrogen antagonists as treatments for sclerosing disorders
#339Styrenyl derivative compounds for treating ophthalmic diseases and disorders
#340METHOD FOR TREATING OR AMELIORATING MUCOCUTANEOUS OR OCULAR TOXICITIES
#341SULFAMOYL BENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS
#342Estrogen receptor ligands and methods of use thereof
#343Metallo-β-lactamase inhibitors
#344Carbocyclic GlyT1 receptor antagonists
#345Composition to retard the onset of symptoms of alzheimer's disease
#346SIGMA RECEPTORS LIGANDS WITH ANTI-APOPTOTIC AND/OR PRO-APOPTOTIC PROPERTIES, OVER CELLULAR MECHANISMS, EXHIBITING PROTOTYPICAL CYTOPROTECTIVE AND ALSO ANTICANCER ACTIVITY
#347Compositions and methods for treating amyloidosis
#348COCKTAIL FOR MODULATION OF ALZHEIMER'S DISEASE
#349Pharmaceutically acceptable salts of betulinic acid derivatives
#350Synthesis of resorcylic acid lactones useful as therapeutic agents
#351Compositions and Methods for Treating Female Sexual Dysfunction
#352ROSAMINE DERIVATIVES AS AGENTS FOR THE TREATMENT OF CANCER
#353Catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition
#354EXTERNAL PREPARATION COMPRISING FATTY ACID SALT OR BENZOIC ACID SALT OF BASIC PHARMACOLOGICALLY ACTIVE COMPONENT, AND METHOD FOR PRODUCTION THEREOF
#355Pharmaceutical Composition for Prevention or Treatment of Disease Associated with Tear Reduction
#356METHOD AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF MENTAL DISORDERS
#357Carbocyclic GlyT-1 receptor antagonists
#358USE OF COMPOUNDS BINDING TO THE SIGMA RECEPTOR LIGANDS FOR THE TREATMENT OF NEUROPATHIC PAIN DEVELOPING AS A CONSEQUENCE OF CHEMOTHERAPY
#359NPY Y5 ANTAGONIST
#360USE OF CHOLINESTERASE INHIBITORS FOR TREATING VASCULAR DEPRESSION
#361Methods for treating drug addiction and improving addiction-related behavior
#362Compositions of tolperisone
#363Inhibitors of NCchannels for therapy
#364NPY Y5 antagonist
#365PROPHYLACTIC AND THERAPEUTIC MEDICINE FOR MALARIA
#366TREATMENT OF NEUROLOGICAL DISORDERS
#367Bicyclic pyrazole compounds as antibacterial agents
#368BICYCLIC PYRAZOLE COMPOUNDS AS ANTIBACTERIAL AGENTS
#369Bicyclic pyrazole compounds as antibacterial agents
#3702,5-disubstituted arylsulfonamide CCR3 antagonists
#371Estrogen receptor ligands and methods of use thereof
#372Compositions Containing Harpagoside and Paeoniflorin and Methods for Treatment of Conditions Associated with Pain, Inflammation, Arthritis and Symptoms Thereof
#373External preparation composition comprising fatty acid-based ionic liquid as active ingredient
#374Fluorene compound and pharmaceutical use thereof
#375Composition for regenerative treatment of cartilage disease
#376MODULATION OF NEUROGENESIS BY NOOTROPIC AGENTS
#377Methods For Assessing, Improving, Or Maintaining Urogenital Health in Postmenopausal Woman
#378Biphenylcarboxamide derivatives as hedgehod pathway modulators
#379USE OF CHOLINESTERASE INHIBITORS FOR TREATING VASCULAR DEPRESSION
#380USE OF PIPERINE AND DERIVATIVES THEREOF FOR THE THERAPY OF NEUROLOGICAL CONDITIONS
#381ESTER COMPOUND AND MEDICAL USE THEREOF
#382Process for the production of high-purity 2,4′-dimethyl-3-piperidino-propiophenone (tolperisone), pharmaceutical compositions that contain the latter, as well as active ingredient formulations that contain tolperisone
#383Systems and Methods for Treating Heart Tissue Via Localized Delivery of Parp Inhibitors
#384Method for the treatment and prevention of ocular disorders
#385NITROXIDES FOR USE IN TREATING OR PREVENTING HYPERCHOLESTEROLEMIA
#386Urea and sulfamide derivatives as inhibitors of TAFIa
#387Methods for controlling SR protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control SR protein activity
#388High penetration prodrug compositions of retinoids and retinoid-related compounds
#389ANTICANCER USE OF CAFFEIC ACID AND ITS DERIVATIVES
#390Aporphine derivatives and pharmaceutical use thereof
#391Pharmaceutically acceptable salts of aporphine derivatives and carboxyl group-containing agents and methods for preparing the same
#392Treatment of Parkinson's disease, obstructive sleep apnea, dementia with Lewy bodies, vascular dementia with non-imidazole alkylamines histamine H-receptor ligands
#393COMBINATION OF MODAFINIL AND AN ANTAGONIST OR INVERSE AGONIST OF THE H3 RECEPTOR
#394Benzamide derivative or salt thereof
#395Compositions and Methods for Treating Female Sexual Dysfunction
#396PHARMACEUTICAL COMBINATIONS
#397COMPOSITIONS OF TOLPERISONE
#398Styrenyl Derivative Compounds for Treating Ophthalmic Diseases and Disorders
#399COCKTAIL FOR MODULATION OF ALZHEIMER'S DISEASE
#400OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
#401CRTH2 Receptor Ligands For Therapeutic Use
#402Compositions and methods for treating amyloidosis
#403TREATMENT OF EPILEPSY WITH NON-IMIDAZOLE ALKYLAMINES HISTAMINE H3-RECEPTOR LIGANDS
#404Guanidine derivatives as inhibitors of DDAH
#405M3 MUSCARINIC RECEPTOR ANTAGONISTS FOR TREATMENT OF M3 MUSCARINIC RECEPTOR-EXPRESSING TUMORS
#406Method of treating neutrophil-related diseases with topical anesthetics
#407Pharmaceutical compositions and methods for preventing, treating, or reversing neuronal dysfunction
#408Novel Pharmaceutical
#409Amino acid derivatives as calcium channel blockers
#410Bisamide inhibitors of hedgehog signaling
#411Composition for Inhibiting Acyl-Coa:Cholesterol Acyltransferase
#412Non Peptide Agonists and Antagonists of Adrenomedullin and Gastric Releasing Peptide
#413Methods and compounds for inhibiting amyloid deposits
#414Controlled Release Pharmaceutical Compositions of Tolperisone for Oral Administration
#415Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
#416Nutritional supplement preparation with piperine
#417Oral preparation of dyclonine hydrochloride
#418Receptor function regulating agent
#419Methods for treating neural cell swelling
#420Phenylalkynes
#421Phenylalkynes
#422Metallo-β-lactamase inhibitors
#423ANTIALLERGIC AGENTS
#424PIPECOLIC ACID-CONTAINING ANTIDIABETIC COMPOSITIONS
#425OMEGA-AMINOALKYLAMIDES OF R-2-ARYL-PROPIONIC ACIDS AS INHIBITORS OF THE CHEMOTAXIS OF POLYMORPHONUCLEATE AND MONONUCLEATE CELLS
#426Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinease Inhibitors
#427Composition for accelerating bone fracture healing
#428ω-carboxyl aryl substituted diphenyl ureas as p38 kinase inhibitors
#429Method for administering tolperisone
#430Alkoxyphenylpropanoic acid derivatives
#431Antiallergic agents
#432Antiallergic agents
#433Benzamide derivative or salt thereof
#434Use of cholinesterase inhibitors for treating vascular depression
#435Composition for regenerative treatment of cartilage disease
#436Method for controlling SR protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control SR protein activity
#437Phenylalkynes
#438Pyrazole compounds and their use as antidiabetes agents
#439NPY Y5 antagonist
#440Adhesive patch for fentanyl administration
#441Antibacterial agents
#442Phenylalkynes
#443Bicyclic pyrazole compounds as antibacterial agents
#444Hydroxamic acid derivatives as antibacterials
#445Combination product comprising an antagonist or inverse agonist of histamine receptor H and an antipsychotic and antidepressant agent, and use thereof for the preparation of a medicament that prevents the adverse effects of psychotropic drugs
#446Pharmaceutical combination for the treatment of spasticity and/or pain
#447Tolperisone-containing pharmaceutical preparation with controllable active-substance release for oral administration
#448Nutritional supplement preparation with piperine
#449Method for treating bruxism and bruxism-related diseases
#450Bioavailability/bioefficacy enhancing activity of and extracts and fractions thereof
#451Antiallergic
#452Methods and compositions using JNK inhibitors for treatment and management of central nervous system injury
#453Method of treating neutrophil-related diseases with topical anesthetics
#454Inhibitors against the activation of ap-1 and nfat
#455HETEROBICYCLIC COMPOUNDS
#456Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
#457Thrombopoetin receptor activator and process for producing the same
#458Spiro compounds, medicinal compositions containing the same and intermediates of the compounds
#459Beta secretase inhibitors
#460Carboxylic acid derivative
#461Methods for assessing, improving, or maintaining urogenital health in postmenopausal woman
#462Tolperisone-containing pharmaceutical preparation with controllable active-substance release for oral administration
#463Methods for treating neural cell swelling
#464Use of estrogen antagonists and estrogen agonists inhibiting pathological conditions
#465Prophylactic and therapeutic agent of diabetes mellitus
#466Use of small molecule compounds for immunopotentiation
#467Alkaloid that inhibits biosynthesis of mycotoxins and method for screening for mycotoxin inhibitors
#468Omega aminoalkylamides of R-2 aryl propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
#469Ester compound and medicinal use thereof
#470Alkaloid that inhibits biosynthesis of mycotoxins and method for screening for mycotoxin inhibitors
#471Antibacterial agents
#472System and method for non-surgical treatment of prolapsed hemorrhoids
#473Topical anesthetics
#474Extended release compositions comprising trihexyphenidyl
#475Method for treating cannabis induced anxiety
#476Apparatus and formulation for treating mouth ulcers
#477Method for treating cannabis induced anxiety
#478Fumarate compounds, pharmaceutical compositions thereof, and methods of use